Glecaprevir plus pibrentasvir for paediatric hepatitis C infection

被引:0
|
作者
Baker, Holly
机构
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:428 / 428
页数:1
相关论文
共 50 条
  • [1] Glecaprevir plus pibrentasvir for treatment of hepatitis C
    Carrion, Andres F.
    Martin, Paul
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (04) : 413 - 419
  • [2] Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection
    Mensa, Federico J.
    Lovell, Sandra
    Pilot-Matias, Tami
    Liu, Wei
    FUTURE MICROBIOLOGY, 2019, 14 (02) : 89 - 110
  • [3] Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection in adults
    Nehra, V
    Rizza, S. A.
    Temesgen, Z.
    DRUGS OF TODAY, 2018, 54 (07) : 407 - 421
  • [4] Glecaprevir/Pibrentasvir Treatment in a Patient with Hemophilia and Mixed Genotype Hepatitis C Infection
    Karasahin, Omer
    Karasahin, Emine Fusun
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2021, 27 (03): : 159 - 161
  • [5] Glecaprevir plus pibrentasvir (ABT493+ABT-530) for the treatment of Hepatitis C
    Hubbard, Hope
    Lawitz, Eric
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (01) : 9 - 17
  • [6] Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection
    Wyles, D.
    Weiland, O.
    Yao, B.
    Reindollar, R.
    Weilert, F.
    Dufour, JF.
    Gordon, S. C.
    Poordad, F.
    Stoehr, A.
    Brown, A.
    Mauss, S.
    Samanta, S.
    Pilot-Matias, T.
    Jr, L. R.
    Trinh, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S23 - S24
  • [7] Glecaprevir/Pibrentasvir (Mavyret) for the Treatment of Chronic Hepatitis C
    Grover, Anupriya
    Erlich, Deborah R.
    AMERICAN FAMILY PHYSICIAN, 2018, 98 (10) : 601 - 602
  • [8] Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir: the SMART-C study
    Dore, Gregory
    Feld, Jordan
    Thompson, Alexander
    Martinello, Marianne
    Muir, Andrew
    Agarwal, Kosh
    Mullhaupt, Beat
    Wedemeyer, Heiner
    Lacombe, Karine
    Matthews, Gail
    Schultz, Michael
    Mercade, Gerard Estivill
    Kho, Danny
    Filep, Ecaterina
    Petoumenos, Kathy
    Marks, Pip
    Tatsch, Fernando
    dos Santos, Ana Gabriela Pires
    Gane, Edward
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E110 - E110
  • [9] Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
    Reau, Nancy
    Kwo, Paul Y.
    Rhee, Susan
    Brown, Robert S., Jr.
    Agarwal, Kosh
    Angus, Peter
    Gane, Edward
    Kao, Jia-Horng
    Mantry, Parvez S.
    Mutimer, David
    Reddy, K. Rajender
    Tran, Tram T.
    Hu, Yiran B.
    Gulati, Abhishek
    Krishnan, Preethi
    Dumas, Emily O.
    Porcalla, Ariel
    Shulman, Nancy S.
    Liu, Wei
    Samanta, Suvajit
    Trinh, Roger
    Forns, Xavier
    HEPATOLOGY, 2018, 68 (04) : 1298 - 1307
  • [10] Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
    Liu, Chen-Hua
    Yang, Sheng-Shun
    Peng, Cheng-Yuan
    Lin, Woan-Tyy
    Liu, Chun-Jen
    Su, Tung-Hung
    Tseng, Tai-Chung
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (06) : 568 - 575